The 27th episode of WIPO’s Mission Imagination series features Charles Gore, Executive Director of the Medicines Patent Pool (MPP), an international organization working to expand access to affordable medicines.
How can we ensure that life-saving medicines reach everyone who needs them? And how can this become a win-win for patients, originator companies, and generics manufacturers?
In conversation with Amy Dietterich, Director, WIPO Global Challenges Division, Charles explains the MPP’s voluntary licensing model, its collaboration with originator and generics companies, expansion into non-communicable diseases, and what lies ahead for the MPP.
Explore other Mission Imagination episodes which focus on Global Health, featuring insights from Ida Tin (Co-founder and Chairwoman of Clue), Norah Magero (mechanical engineer and Co-founder of Drop Access), Patrick Tippoo (Chief Science and Innovation Officer at Biovac), Dr. Richard Hatchett (CEO of CEPI), Kemisola Bolarinwa (Inventor of “SmartBra”), and Josefa Cortés (Founder of Palpa).
About Medicines Patent Pool
The Medicines Patent Pool is a United Nations-backed public health organization focused on increasing access to and facilitating the development of life-saving medicines for low- and middle-income countries.
About WIPO Global Health Unit
The Global Health Unit at WIPO seeks to raise awareness and understanding of the linkages among global health, innovation, and access to medical technologies.